Arend von Stackelberg

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 605 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

Peter Bader, Hermann Kreyenberg, Günter Henze et al. · Journal of Clinical Oncology · 2008 · 358 citations · Full text

Medicine, Oncology, Pediatrics +14

Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian et al. · European Journal of Cancer · 2016 · 336 citations · Full text

Medicine, Oncology, Pediatrics +11

Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study

Christina Peters, Jean‐Hugues Dalle, Franco Locatelli et al. · Journal of Clinical Oncology · 2020 · 329 citations · Full text

Medicine, Hematology, Oncology +17

Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia

Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari et al. · JAMA · 2021 · 325 citations · Full text

Medicine, Hematology, Pediatrics +17